Breast Cancer,Other Cancers Tucatinib and Trastuzumab Combo as Maintenance Therapy for HER2+ Breast Cancer May 15, 2023
Breast Cancer,Other Cancers PIK3CA and ESR1 Mutations in Circulating Tumor DNA: MONARCH-2 Study Analysis May 15, 2023
Breast Cancer,Other Cancers MAINTAIN Trial: Fulvestrant or Exemestane +/- Ribociclib After Progression on CDK 4/6I for HR+, HER2- MBC May 10, 2023
Breast Cancer,Other Cancers MINDACT Trial: Patients with Ultralow-Risk 70-Gene Signature Show Positive Outcome May 10, 2023
Breast Cancer,Other Cancers Node-Positive Breast Cancer Patients Can Use the 21-Gene Assay to Determine Chemo Benefit, Study Finds May 10, 2023
Breast Cancer,Other Cancers ALP + ET in PIK3CA-mutated HR+/HER2- ABC: Baseline analysis and PFS by prior CDK4/6i duration (BYLieve) May 10, 2023
Breast Cancer,Other Cancers Alpelisib + Fulvestrant in HR+/HER2- Advanced Breast Cancer: Biomarker Analyses From SOLAR-1 NGS Study May 10, 2023
Breast Cancer,Other Cancers The Power of PADA-1: Palbociclib and Circulating Tumor DNA in Detecting ESR1 Mutations May 10, 2023
